The influence of hormone therapy with drospirenone-estradiol on endometrioid type endometrial cancer patients.

Published in: Journal of gynecologic oncology (2018)

Postoperative hormone therapy with DRSP/E2 in EC survivors did not increase recurrence or the death rate.

Keyphrases